HHHamidreza Hekmat

Hamidreza Hekmat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hamidreza Hekmat has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Applicability of Stress Cardiac Magnetic Resonance Imaging in Patients With Cardiac Implantable Devices: A Systematic Review

    by Sarina Zakavi, Mohammad Rafie Khorgami, Pedram Babaee, Alireza Babaeizadeh, Rahem Rahmati, Mina Felfeli, Elahe Meftah, Golnaz Houshmand, Fatemeh Abedpour, Amirfarjam Fazelifar, et al.

    Purpose: The utilization of stress perfusion cardiac magnetic resonance (CMR) in patients with cardiac implantable electronic devices (CIEDs) is still limited. Methods: The study was registered in the Prospective Register of Systematic Reviews (PROSPERO) with ID CRD42023457308. PubMed, Scopus, Embase, Web of Science, ProQuest, and CINAHL databases were searched using the Mesh and related terms of CMR imaging, stress, and CIEDs. Results: Out of the 1695 papers we found, eight met our inclusion criteria. We reviewed the included studies and provided a concluding remark concerning (a) image quality; (b) CMR compatibility, scanner, and safety; (c) device protocols and exclusion criteria; (d) vasodilator choices, effects, and safety; and (e) clinical outcomes. Conclusion: This study has demonstrated a positive trend in the utilization of stress CMR in MR‐conditional devices. However, the review has identified multiple research gaps that warrant further investigation.

  • Mid‐Term Clinical Outcomes and Predictors of Mortality and Major Adverse Cardiovascular Events Following Cardiac Valve Replacement Surgery: A Retrospective Cohort Study From a Tertiary Center in Iran

    by Homina Saffar, Nadia Rajablou, Abbasali Karimi, Shahrzad Salehbeygi, Soheil Mansourian, Hamidreza Pourhosseini, Arezou Zoroufian, Mohammad Sahebjam, Reza Mohseni‐Badalabadi, Reza Hali, et al.

    Objectives: Valvular heart disease (VHD) is a growing global health concern with increasing prevalence, particularly in aging populations. While surgical valve replacement (VRS) remains a definitive treatment, limited data exists from developing countries regarding postoperative outcomes. This study aimed to evaluate mid‐term clinical outcomes, specifically survival and major adverse cardiovascular events (MACE), in patients undergoing isolated mitral and aortic valve replacement surgery, and to identify factors associated with mortality. Methods: In this retrospective cohort study, 1044 patients who underwent isolated mitral or aortic VRS at Tehran Heart Center between 2003 and 2023 were analyzed. Demographic, clinical, and echocardiographic data were collected. The primary outcome was all‐cause mortality; the secondary outcome was MACE. Statistical analyses included univariate and multivariate Cox regression, ROC curve analysis, and log‐rank tests. Results: The mean age of patients was 55 years, and 52% were male. Over a mean follow‐up of 23.9 months, the overall mortality rate was 4.3%, and 8.4% experienced MACE. Multivariate analysis identified older age ( p = 0.002) and female gender ( p = 0.006) as independent predictors of mortality. Age > 50 years had a sensitivity of 85.5% and specificity of 34% for predicting mortality (AUC = 0.639, p = 0.001). No significant predictors of MACE were identified. Conclusion: Advanced age and female gender were associated with increased mortality following isolated VRS. These findings underscore the importance of tailored preoperative risk assessment to optimize surgical outcomes, particularly in developing healthcare settings.


  • Open Access

    Exploring the Complex Challenges of Heart Failure: Healthcare Costs, Access, and Social Factors in Iran

    by Hamidreza Hekmat, Alireza Namazi Shabestari, Fatemeh Sadat Mirzadeh

    Introduction: Heart failure and cardiovascular diseases pose significant health challenges in Iran and beyond, straining healthcare systems and impacting patients' quality of life due to costs and access issues. Understanding the management challenges of these conditions is essential for improving health outcomes. Methods: This study explores the challenges of heart ...

  • Open Access

    Spontaneous coronary artery dissection in the context of tamoxifen; Is there any correlation?

    by Homina Saffar, Leili Abdan, Zahra Abdan, Hamidreza Hekmat, Alireza Amirzadegan, Negar Omidi

    Key Clinical Message: Clinicians should consider spontaneous coronary artery dissection in middle‐aged women presenting with acute coronary syndromes and a history of tamoxifen use, to ensure timely diagnosis, and appropriate management strategies. Spontaneous coronary artery dissection (SCAD) is characterized by a non‐iatrogenic, nontraumatic separation of the coronary artery wall, contributing to acute coronary syndromes (ACS), and sudden cardiac death. SCAD predominantly affects the left anterior descending artery (LAD) and is frequently observed in middle‐aged women. This condition has been associated with cancer treatment and exogenous hormones exposure. The diagnostic gold standard remains coronary angiography, management strategies include conservative measures, percutaneous coronary intervention (PCI), and coronary artery bypass graft surgery (CABG). We describe a case of a 54‐year‐old woman with breast cancer and a history of tamoxifen use, presenting with SCAD in the posterolateral branch (PLB) originating from the left circumflex artery (LCX), and right coronary artery (RCA) and managed conservatively.


  • Open Access

    A Review of Antibiotic Efficacy in COVID-19 Control

    by Hamidreza Hekmat, Aziz Rasooli, Zeinab Siami, Kauthar Amir Rutajengwa, Zahra Vahabi, Fatemeh Alsadat Mirzadeh

    Severe acute respiratory disease is associated with chronic secondary infections that exacerbate symptoms and mortality. So far, many drugs have been introduced to treat this disease, none of which effectively control the coronavirus. Numerous studies have shown that mitochondria, as the center of cell biogenesis, are vulnerable to drugs, especially antibiotics. Antibiotics were widely prescribed during the early phase of the pandemic. We performed a literature review to assess the reasons, evidence, and practices on the use of antibiotics in coronavirus disease 2019 (COVID-19) in- and outpatients. The current research found widespread usage of antibiotics, mostly in an empirical context, among COVID-19 hospitalized patients. The effectiveness of this approach has not been established. Given the high death rate linked with secondary infections in COVID-19 patients and the developing antimicrobial resistance, further study is urgently needed to identify the most appropriate rationale for antibiotic therapy in these patients.


  • Open Access

    Diffuse alveolar hemorrhage; An under-diagnosed and rare complication of glycoprotein IIb/IIIa inhibitors

    by Hamidreza Hekmat, Zahra Vahabi, Maryam Shojaeifard, Fatemeh Sadat Mirzadeh

    Glycoprotein IIb/IIIa inhibitors play a key role in the treatment of patients who have acute coronary syndromes and undergone percutaneous coronary intervention. However, its serious complication is diffused alveolar hemorrhage. A 73-year-old diabetic woman presented with chest pain and dynamic ST elevation in ECG and positive troponin. She had occlusion in two coronary arteries and underwent percutaneous coronary intervention. The eptifibatide was administered. After hours, she showed respiratory symptoms, as well as drop of blood pressure and hemoglobin. All differential diagnoses suggested for her clinical presentation were evaluated, and finally, on the sixth day diffuse alveolar hemorrhage was diagnosed. Although respiratory symptoms such as hemoptysis and dyspnea may occur as complications of pulmonary edema and/or pneumonia, assumed clinical suspicion for pulmonary hemorrhage leading to early detection of it. Moreover, there is no definitive guideline for decreased bleeding complications and treatment of alveolar hemorrhage caused by glycoprotein IIb/IIIa receptor inhibitors.


  • Open Access

    The outcomes of marginal donor hearts compared with ideal donors: a single-center experience in Iran

    by Behnam Shakerian, Sanaz Dehghani, Haleh Ashraf, Shahrokh Karbalai, Abbas Soleimani, Atieh Rezaeefar, Zahra Shajari, Hamidreza Hekmat, Marzieh Latifi, Azadeh Sadatnaseri

    Behnam Shakerian, Sanaz Dehghani, Haleh Ashraf, Shahrokh Karbalai, Abbas Soleimani, Atieh Rezaeefar, Zahra Shajari, Hamidreza Hekmat, Marzieh Latifi, Azadeh Sadatnaseri. Korean J Transplant 2022;36:136-42. https://doi.org/10.4285/kjt.22.0004


  • Open Access

    Role of frailty in prediction of hospitalized older adult patient’s outcomes: a prospective study

    by Maryam Chehrehgosha, Reza Fadaye Vatan, Mahtab Alizadeh-Khoei, Farshad Sharifi, Reyhaneh Aminalroaya, Zahra Vahabi, Abolfazl Zendedel, Hamidreza Hekmat

    Frailty is associated with an increased risk of negative short-term and long-term hospital outcomes. This study aimed to evaluate the role of frailty in predicting readmission, length of stay, and quality of life in the hospitalized older adults. This observational study was conducted at Ziaiyan Hospital, Tehran, Iran. 304 participants (65-85 years), were enrolled through the inclusion criteria from August to December 2019. The Frailty Index (FI) was assessed by the Minimum Data Set-Home Care. Readmission was obtained through telephone interviews. The length of stay was gathered by the patient?s hospital records, and the EuroQol questionnaire was used for assessing the quality of life. Data were collected by a researcher nurse at the admission time, 30, 60, and 90 days after discharge. The logistic regression model and repeated measures ANOVA were employed to analyze the association between frailty and outcomes. According to FI, 102 (33.55%) participants were pre-frail, whereas 35 (11.51%) were frail. In the fully-adjusted model for readmission, the pre-frail participants had a higher risk of readmission at the hospital in comparison with the non-frail and frail groups (OR=1.88, 95% CI =1.90?3.26), and also for GP visits, frail patients showed nearly signi?cant differences (OR =2.45, 95% CI =0.99?6.06) but there were no differences between frail and pre-frail patients in readmissions in the emergency ward. In a fully-adjusted prolonged stay model, pre-frail patients had a higher probability to stay longer in hospital (OR =2.28, 95% CI: 1.24 - 4.18). The fully-adjusted model for QoL showed, frail patients were more prone to the declined levels of QoL in comparison with pre-frail patients (OR =10.77, 95% CI: 3.97 - 29.18). The findings indicated that frailty worsened negative outcomes and declined QoL. Early diagnosis in hospital settings could be beneficial for designing optimal care plans for the frail and pre-frail patients.


  • Open Access

    Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review

    by Masoumeh Mohamadi, Azadeh Goodarzi, Armin Aryannejad, Nima Fattahi, Mahtab Alizadeh-Khoei, Shahnaz Miri, Hamidreza Hekmat, Moloud Payab, Mohammad Bodaghabadi